A study led by researchers from the Dementia Neurobiology Group at the Sant Pau Research Institute, published 6 May 2024 in the journal Nature Medicine, has identified that almost all individuals with two copies of the APOE4 gene develop signs of Alzheimer’s.
From pacemakers to neurostimulators, implantable medical devices rely on batteries to keep the heart on beat and dampen pain. But batteries eventually run low and require invasive surgeries to replace. To address these challenges, researchers in China devised an implantable battery that runs on oxygen in the body. The study, published March 27 in the […]
When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations and can sometimes generate incorrect advice or instructions. A new study [1] in the American Journal of Preventive Medicine, assesses the accuracy and reliability of […]
eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, and PorMedTec, a global leader in porcine embryology, have successfully produced genetically engineered porcine donors in Japan for use in transplantation.
Aston University has hosted an event to celebrate the launch of SPARK The Midlands www.sparkthemidlands.co.uk, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.
An initiative with the aim of building stronger relationships between the NHS and industry was recently hosted and organised by the Imperial College Healthcare NHS Trust, in partnership with the Shelford Group and the Association of British HealthTech Industries (ABHI).
Affluent Medical, a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, has carried out a successful first-in-human implantation of the minimally invasive medical device Artus for the treatment of urinary incontinence as part of the European pilot study ‘Dry’.
Ultrahuman, a pioneer in wearable tech, has raised $35 million in equity and debt investment. The series B funding round saw participation from venture capital firms Blume, Steadview, Nexus, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will use the funds to build more manufacturing capacity and expand research in the health tracking space.
An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has begun following a meeting in February in Utrecht, the Netherlands.
Researchers in France have embarked on a four-year project to test the new non-invasive technique, that could help surgeons quickly and accurately assess patients for potentially life-changing complications after neck surgery. The research could have global relevance.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
